ClinicalTrials.Veeva

Menu

Autologous Patch Healing vs. Secondary Intention Healing After Mohs Micrographic Surgery

B

Bispebjerg Hospital

Status

Enrolling

Conditions

Skin Cancer
Basal Cell Carcinoma

Treatments

Procedure: MMS + Autologous patch
Procedure: MMS and secondary intention healing

Study type

Interventional

Funder types

Other

Identifiers

NCT05170035
Autologous Patch-project

Details and patient eligibility

About

The primary objects of this study is to explore the potential effect of the autologous patch to optimize wound healing after skin cancer surgery with Mohs micrographic surgery (MMS) in the face in a randomized controlled trial comparing autologous patch healing versus secondary intention healing.

Enrollment

26 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Subjects undergoing MMS for biopsy verified primary nodular basal cell carcinoma in the face, head and neck area on a location suitable for secondary intention healing and thus may also be suitable for autologous patch healing
  2. Presenting relevant medical record report at study initiation
  3. Written informed consent obtained from subject
  4. Understanding of investigation procedures and willingness to abide to all procedures during the course of the investigation.

Exclusion criteria

  1. A subjects with major systemic disease not yet stabilized
  2. Significant history or current evidence of a medical, psychological or other disorder that, in the investigator's opinion, would preclude enrollment into the study.
  3. Pregnant or breast feeding
  4. Unable to follow the outlined study protocol
  5. Participation in other studies at the same time that may affect the wound healing.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

26 participants in 2 patient groups

MMS + Autologous patch
Experimental group
Description:
Mohs micrographic surgery + Autologus patch formed from 18 ml venous blood sample collected from the patient + polymycin-terramycin B ointment and a Jelonet applied on top of the patch.
Treatment:
Procedure: MMS + Autologous patch
MMS + Secondary intention healing
Active Comparator group
Description:
Mohs micropgraphic surgery + Polymycin-terramycin B ointment + dry wound dressing
Treatment:
Procedure: MMS and secondary intention healing

Trial contacts and locations

1

Loading...

Central trial contact

Anna A Harager, Bsc; Katrine E Karmisholt, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems